Literature DB >> 22509428

HLA-targeted cell sorting of microchimeric cells opens the way to phenotypical and functional characterization.

Michael Eikmans1, Frans H J Claas.   

Abstract

Microchimerism refers to the presence of less than 1% of non-host cells in a person. Our group developed a reliable method for separating viable microchimeric cells from the host environment. Optimal separation of microchimeric cells at proportions as low as 0.01% could be established with two monoclonal antibodies directed against different HLA antigens, one targeting the microchimeric cells and the other the host cells. Purity of separated cell populations was validated by HLA-allele-specific and Y-chromosome directed real-time qPCR assays. The methodology was used successfully to separate microchimeric maternal cells from child umbilical cord mononuclear cells after pregnancy. Cell sorting with HLA monoclonal antibodies targeting allelic differences enables reliable microchimeric cell detection and separation in blood specimens. With this approach, maximal enrichment of potentially viable microchimeric cells from a background cell population is reached, which opens the way to phenotypical and functional characterization of microchimeric cells.

Entities:  

Keywords:  FACS; HLA; cell sorting; microchimerism; monoclonal antibodies

Mesh:

Substances:

Year:  2011        PMID: 22509428      PMCID: PMC3321882          DOI: 10.4161/chim.2.4.19133

Source DB:  PubMed          Journal:  Chimerism        ISSN: 1938-1964


  30 in total

1.  Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity.

Authors:  Florence Bettens; Jean-Marie Tiercy; Nathalie Campanile; Emiliano Giostra; Pietro Majno; Laura Rubbia; Eddy Roosnek; Gilles Mentha; Jean Villard
Journal:  Liver Transpl       Date:  2005-03       Impact factor: 5.799

2.  Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis.

Authors:  C M Artlett; J B Smith; S A Jimenez
Journal:  N Engl J Med       Date:  1998-04-23       Impact factor: 91.245

3.  Microchimerism of maternal origin persists into adult life.

Authors:  S Maloney; A Smith; D E Furst; D Myerson; K Rupert; P C Evans; J L Nelson
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

4.  Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts.

Authors:  S Tamaki; T Ichinohe; K Matsuo; N Hamajima; N Hirabayashi; H Dohy
Journal:  Bone Marrow Transplant       Date:  2001-08       Impact factor: 5.483

5.  Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life.

Authors:  F H Claas; Y Gijbels; J van der Velden-de Munck; J J van Rood
Journal:  Science       Date:  1988-09-30       Impact factor: 47.728

6.  Maternal and fetal microchimerism in granulocytes.

Authors:  Chennakesava Cuddapah Sunku; Vijayakrishna K Gadi; Berengere de Laval de Lacoste; Katherine A Guthrie; J Lee Nelson
Journal:  Chimerism       Date:  2010 Jul-Sep

7.  Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

Authors:  Jon J van Rood; Cladd E Stevens; Jacqueline Smits; Carmelita Carrier; Carol Carpenter; Andromachi Scaradavou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

8.  PCR-based methodology for molecular microchimerism detection and quantification.

Authors:  Josep-Maria Pujal; David Gallardo
Journal:  Exp Biol Med (Maywood)       Date:  2008-06-05

9.  Patterns of donor-type microchimerism after heart transplantation.

Authors:  H J Schlitt; J Hundrieser; M Hisanaga; K Uthoff; M Karck; T Wahlers; K Wonigeit; R Pichlmayr
Journal:  Lancet       Date:  1994-06-11       Impact factor: 79.321

10.  Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury.

Authors:  Yu Wang; Hirotsugu Iwatani; Takahito Ito; Naoko Horimoto; Masaya Yamato; Isao Matsui; Enyu Imai; Masatsugu Hori
Journal:  Biochem Biophys Res Commun       Date:  2004-12-17       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.